[1-(2-Bromobenzyl)piperidin-4-yl]methanamine dihydrochloride, 95.0%, 1g

Methyl 3-aminofuro[2,3-b]pyridine-2-carboxylate, 97%, 100mg

Methyl 2-(pyridin-3-yl)acetate, 95.0%, 10g

1-(4-Fluoro-phenyl)-propylamine, 95.0%, 100mg

8a-Methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione, 98.5%, 1g

N-(3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl)-2-(1,3-dioxoisoindolin-2-yl)acetamide, 97%, 1g

methyl 3-(2-amino-4-hydroxy-6-methyl-5-pyrimidinyl)propanoate, 95.0%, 5g

5-chloro-6-nitro-2,3-dihydro-1H-indole, 95.0%, 5g

Tetramethylhydroquinone; >95%, 95.0%, 1g

Solution indicatrice d'o-crésolphtaléine, 0,1 % dans l'éthanol, dénaturée, 250 ml, emballage plastique.

4-(1H-Imidazol-1-yl)benzoic acid hydrochloride, 95%, 250mg

Boîtes carrées ROTILABO® forme haute, 1500 ml, 20 Pièce(s)

Tert-butyl 4-bromo-2-formyl-1H-pyrrole-1-carboxylate, 250mg